• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Myosin Modulation in Hypertrophic Cardiomyopathy and Systolic Heart Failure: Getting Inside the Engine.

作者信息

Daniels Matthew J, Fusi Luca, Semsarian Christopher, Naidu Srihari S

机构信息

Manchester Heart Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, United Kingdom (M.J.D.).

Division of Cardiovascular Sciences, Manchester Academic Health Sciences Center (M.J.D.), University of Manchester, Manchester, United Kingdom.

出版信息

Circulation. 2021 Sep 7;144(10):759-762. doi: 10.1161/CIRCULATIONAHA.121.056324.

DOI:10.1161/CIRCULATIONAHA.121.056324
PMID:34491773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7611636/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d0/7611636/471d800f56a4/EMS132025-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d0/7611636/471d800f56a4/EMS132025-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d0/7611636/471d800f56a4/EMS132025-f001.jpg

相似文献

1
Myosin Modulation in Hypertrophic Cardiomyopathy and Systolic Heart Failure: Getting Inside the Engine.肥厚型心肌病和收缩性心力衰竭中的肌球蛋白调节：深入探究其机制
Circulation. 2021 Sep 7;144(10):759-762. doi: 10.1161/CIRCULATIONAHA.121.056324.
2
Accumulation and assembly of myosin in hypertrophic cardiomyopathy with the 403 Arg to Gln beta-myosin heavy chain mutation.在具有403位精氨酸突变为谷氨酰胺的β-肌球蛋白重链突变的肥厚型心肌病中肌球蛋白的积累与组装
Circ Res. 1992 Dec;71(6):1404-9. doi: 10.1161/01.res.71.6.1404.
3
Measurement of Myofilament-Localized Calcium Dynamics in Adult Cardiomyocytes and the Effect of Hypertrophic Cardiomyopathy Mutations.测量成年心肌细胞肌丝钙动力学及其肥厚型心肌病突变的影响。
Circ Res. 2019 Apr 12;124(8):1228-1239. doi: 10.1161/CIRCRESAHA.118.314600.
4
Hypertrophic cardiomyopathy mutations in dysregulate myosin.肥厚型心肌病突变会扰乱肌球蛋白。
Sci Transl Med. 2019 Jan 23;11(476). doi: 10.1126/scitranslmed.aat1199.
5
Hypertrophic cardiomyopathy: a practical approach to guideline directed management.肥厚型心肌病：指南导向管理的实用方法。
Lancet. 2021 Dec 4;398(10316):2102-2108. doi: 10.1016/S0140-6736(21)01205-8. Epub 2021 Sep 30.
6
Systolic heart failure in a patient with hypertrophic obstructive cardiomyopathy: a potentially life-threatening complication.肥厚型梗阻性心肌病患者的收缩性心力衰竭：一种潜在的危及生命的并发症。
Crit Care Nurse. 2008 Oct;28(5):44-52; quiz 53.
7
Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.肥厚型心肌病β-肌球蛋白突变（P710R）通过破坏超级松弛状态导致过度收缩。
Proc Natl Acad Sci U S A. 2021 Jun 15;118(24). doi: 10.1073/pnas.2025030118.
8
A Failure to Communicate: MYOSIN RESIDUES INVOLVED IN HYPERTROPHIC CARDIOMYOPATHY AFFECT INTER-DOMAIN INTERACTION.沟通障碍：肥厚型心肌病中涉及的肌球蛋白残基影响结构域间相互作用。
J Biol Chem. 2015 Dec 4;290(49):29270-80. doi: 10.1074/jbc.M115.681874. Epub 2015 Oct 7.
9
Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.兔肌球蛋白β亚基 R403Q 突变型肥厚型心肌病降低分子和肌原纤维水平的收缩功能。
Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):11238-11243. doi: 10.1073/pnas.1802967115. Epub 2018 Oct 15.
10
Structural and enzymatic comparison of human cardiac muscle myosins isolated from infants, adults, and patients with hypertrophic cardiomyopathy.从婴儿、成人以及肥厚型心肌病患者中分离出的人类心肌肌球蛋白的结构与酶活性比较。
J Clin Invest. 1982 Apr;69(4):816-25. doi: 10.1172/jci110521.

引用本文的文献

1
Progression from cardiomyopathy to heart failure with reduced ejection fraction: A CORIN deficient course.从心肌病进展为射血分数降低的心力衰竭：CORIN缺乏的病程。
Heliyon. 2024 Sep 11;10(18):e37838. doi: 10.1016/j.heliyon.2024.e37838. eCollection 2024 Sep 30.
2
Medical Therapies to Improve Left Ventricular Outflow Obstruction and Diastolic Function in Hypertrophic Cardiomyopathy.改善肥厚型心肌病左心室流出道梗阻和舒张功能的医学疗法。
JACC Adv. 2023 Sep 25;2(8):100622. doi: 10.1016/j.jacadv.2023.100622. eCollection 2023 Oct.
3
HAPLN1 knockdown inhibits heart failure development via activating the PKA signaling pathway.

本文引用的文献

1
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.肌球蛋白激活治疗收缩性心力衰竭的奥马曲珠单抗
N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797. Epub 2020 Nov 13.
2
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.马卡丹特治疗有症状梗阻性肥厚型心肌病（EXPLORER-HCM）的随机、双盲、安慰剂对照、3 期临床试验
Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29.
3
The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin.
HAPLN1 敲低通过激活 PKA 信号通路抑制心力衰竭的发展。
BMC Cardiovasc Disord. 2024 Apr 5;24(1):197. doi: 10.1186/s12872-024-03861-8.
4
Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.阿非卡肽：治疗梗阻性肥厚型心肌病症状的突破性疗法。
Am J Cardiovasc Drugs. 2023 Sep;23(5):519-532. doi: 10.1007/s40256-023-00599-0. Epub 2023 Aug 1.
5
Comparing the effects of chemical Ca dyes and R-GECO on contractility and Ca transients in adult and human iPSC cardiomyocytes.比较化学 Ca 染料和 R-GECO 对成年和人诱导多能干细胞心肌细胞收缩性和 Ca 瞬变的影响。
J Mol Cell Cardiol. 2023 Jul;180:44-57. doi: 10.1016/j.yjmcc.2023.04.008. Epub 2023 Apr 29.
6
Mavacamten: A First-in-class Oral Modulator of Cardiac Myosin for the Treatment of Symptomatic Hypertrophic Obstructive Cardiomyopathy.玛伐卡坦：用于治疗有症状的肥厚性梗阻性心肌病的首款心脏肌球蛋白口服调节剂。
Heart Int. 2022 Oct 5;16(2):91-98. doi: 10.17925/HI.2022.16.2.91. eCollection 2022.
7
Astragaloside IV promotes pharmacological effect of seeds on isoproterenol-induced cardiomyopathy in rats by synergistically modulating the myosin motor.黄芪甲苷通过协同调节肌球蛋白运动，促进种子对异丙肾上腺素诱导的大鼠心肌病的药理作用。
Front Pharmacol. 2022 Aug 11;13:939483. doi: 10.3389/fphar.2022.939483. eCollection 2022.
8
The Interventricular Septum: Structure, Function, Dysfunction, and Diseases.室间隔：结构、功能、功能障碍及疾病
J Clin Med. 2022 Jun 6;11(11):3227. doi: 10.3390/jcm11113227.
9
Structural basis of the super- and hyper-relaxed states of myosin II.肌球蛋白 II 的超松弛和超超松弛状态的结构基础。
J Gen Physiol. 2022 Jan 3;154(1). doi: 10.1085/jgp.202113012. Epub 2021 Dec 10.
肥厚型心肌病突变 R403Q 和 R663H 增加了与肌动蛋白相互作用的肌球蛋白头部数量。
Sci Adv. 2020 Apr 3;6(14):eaax0069. doi: 10.1126/sciadv.aax0069. eCollection 2020 Apr.
4
Myosin filament-based regulation of the dynamics of contraction in heart muscle.基于肌球蛋白丝的心肌收缩动力学调节。
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):8177-8186. doi: 10.1073/pnas.1920632117. Epub 2020 Mar 27.
5
Measurement of Myofilament-Localized Calcium Dynamics in Adult Cardiomyocytes and the Effect of Hypertrophic Cardiomyopathy Mutations.测量成年心肌细胞肌丝钙动力学及其肥厚型心肌病突变的影响。
Circ Res. 2019 Apr 12;124(8):1228-1239. doi: 10.1161/CIRCRESAHA.118.314600.